| Patient factors | Procedural factors |
| Immunocompromise inc. diabetes | Difficult insertion or bloody tap |
| Local or systemic infection | Long duration of epidural in situ |
| Disrupted spinal column e.g. surgery, trauma | Prolonged hospital stay |
| Long-term vascular access | |
| IVDU |
Reducing risk
- Insertion in as sterile a fashion as possible
- If using an ultrasound ensure it is properly cleaned and use a single-use sterile transducer cover
- Guidelines recommend skin preparation with 0.5% chlorhexidine gluconate in 70% alcohol and allowing adequate time to dry
- 2% chlorhexidine offers no greater antimicrobial benefit but increases risk of neurotoxicity
- Turns out we're not all that good at adhering to a totally aseptic technique
- Avoid using catheters in peripheral nerve blocks (as higher rate of infection than single shot block)
- Remove epidural catheter ASAP, ideally after ≤72hrs
- Regular catheter-site checks
- Regular temperature monitoring
- Neuro-observations for those with epidural in situ